Skip to main content
Premium Trial:

Request an Annual Quote

Microarray Developer NimbleGen Raises $9M in Latest Financing Round

NEW YORK, Sept 11 – Microarray developer NimbleGen Systems of Madison, Wis., said Tuesday it had raised $9 million in a private round of financing.

The company has raised more than $12.5 million in total.

Investors in the recent round of financing included new investors such as Venture Investors Management, Baird Venture Partners, and State of Wisconsin Investment Board. Previous investors including Skyline Ventures, Tactics II Investments, and The Wisconsin Alumni Research Foundation also participated in the financing round.

NimbleGen produces customized high-density DNA arrays using technology based on digital mirrors. The company said its system is capable of producing specialized arrays in less than four hours.

The company said that it has so far completed the first “pre-manufacturing run” of high-density arrays and that the technology was developing at a “very rapid” pace.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more